Oversold

PDEX

Valuation45/ 100
Cash flow & growth72/ 100
Upside potential34/ 100
Risk potential39/ 100

PDEX's valuation appears fair, fundamentals are above averages, but expected margin pressure tempers an otherwise stable outlook, though analyst coverage is limited.

Score change since last week

The score fell 3 points, mainly due to valuation and price changes. Price rose 17.3%, from $62.56 to $73.41. Reported annual EPS changed from $3.63 to $4.12.

Valuation and price changes subtracted 1.5 points. Business results and financial strength subtracted 1.1 points. The comparison uses the same available inputs on both dates. Displayed changes are rounded to whole points.

Valuation

Historical cheapness: current PE is 17.8× versus the full-history median of 16.4× shown in the valuation table, producing 44.1/100. Positive weekly observations receive equal weight; lower past EPS alone does not disqualify them.

Outlook-adjusted valuation: 45.1/100. The model applies a 12.2% earnings-growth assumption and a 10% annual return hurdle, with positive credit limited by evidence coverage and confidence.

Forward price scenarios use recent PE history separately. Recent history has a separately weighted median of 15.6× (18-month half-life). The favorable scenario uses 16.5× PE and $5 projected EPS, informed by growth, margins and earnings-quality checks. This is a model scenario, not an analyst target. A return to the full-history median is not assumed.

Cash flow & growth

Business trends are strong. Over the past year: revenue +16.4%, earnings +52.6%, operating margin +0.7 percentage points. Free cash flow is 8.9% of revenue. The business score is 72.1/100. Growth, margins and cash generation drive the score. Missing or older data receives less weight.

Favorable scenario

The earnings calculation and the displayed scenario are different.

The earnings case uses $4.99 of EPS and a 16.5× PE, suggesting about $82.59 before the minimum is applied. Valuation history and outlook inform the PE.

The model applies a 15% minimum upside scenario, so the card shows +15%, or about $84.42. That adjusted price does not come from the EPS × PE calculation above.

This is a scenario based on our model, not a forecast or probability.

Downside scenario

Weaker than expected earnings could put pressure on the share price.

Our downside case uses $3.50 of EPS and a 12.8× PE, suggesting a share price of about $44.73 — 39% below today’s price. Valuation history and outlook inform the PE.

This is a scenario based on our model, not a forecast or probability.

PDEX vs Historical averages

MetricCurrentAverageRelative
PE18x17x2% higher
PE percentile665032% higher
EPS$4.12$1.74137% higher
FCF$6.9M$128.7K5,254% higher
Loading historical comparisons…

PDEX’s earnings and cash flow are above their historical averages, while its earnings multiple is higher.

PDEX Forward outlook

MetricOutlook
Forward valuationStable
Forward earningsStable
Forward revenueStable
Forward profitabilityStrongly contracting
Analyst coverageLimited
Estimate dispersionTight

PDEX’s outlook is generally stable, with narrowing profit margins the main concern.

PDEX PE Valuation

Loading pe valuation table…

This table applies PDEX's historical price-to-earnings (PE) landmarks to current earnings. The implied prices are valuation scenarios, not price forecasts or targets.

PDEX Earnings Per Share

Loading earnings per share…

This chart tracks PDEX's trailing twelve-month diluted earnings per share, calculated from four consecutive reported quarters to reduce seasonal noise.

PDEX Quarterly Revenue

Loading quarterly revenue…

This chart tracks PDEX's quarterly revenue over time and shows how sales are changing from year to year.

PDEX Free Cash Flow

Loading free cash flow…

This chart tracks PDEX's free cash flow over time, showing whether the business is consistently generating cash after operating costs and capital spending.

PDEX Total Shares

Loading shares over time…

This chart tracks changes in PDEX's diluted share count. A rising count can dilute existing owners, while a falling count often reflects share repurchases.

PDEX Net Leverage

Loading net leverage…

Quarterly Net Leverage uses the last 12 months of EBITDA. A falling multiple generally indicates less debt relative to earnings capacity. Negative values mean net cash; missing data or nonpositive LTM EBITDA are N/A. The table shows each period’s Net Leverage and status.

PDEX PE vs Healthcare Sector

Loading pe vs sector average…

This chart compares PDEX's price-to-earnings (PE) ratio with the Healthcare sector average. A discount or premium can reflect differences in expected growth, profitability, or risk.

PDEX Weekly Price

Loading weekly price…

This chart uses PDEX's weekly closing prices to show the longer-term trend. The lower panes show weekly RSI and Stochastic momentum.

PDEX Weekly Moving Averages

Loading weekly moving averages…

This chart compares PDEX's 8, 20, 50, 100, and 200-week moving averages from 2020 onward. Shorter averages react faster to price changes, while longer averages show the broader trend.

PDEX Yearly ROI

Loading yearly ROI…

Each line starts at 0% using the year’s first dependable weekly close and tracks the return through December, or through the latest available week for the current year.